These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27396304)

  • 21. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs change the games in central nervous system pharmacology.
    Marangon D; Raffaele S; Fumagalli M; Lecca D
    Biochem Pharmacol; 2019 Oct; 168():162-172. PubMed ID: 31251938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of microRNAs in neurodegenerative diseases: a review.
    Li S; Lei Z; Sun T
    Cell Biol Toxicol; 2023 Feb; 39(1):53-83. PubMed ID: 36125599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
    Nguyen DD; Chang S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases.
    You HJ; Park JH; Pareja-Galeano H; Lucia A; Shin JI
    Neuromolecular Med; 2016 Dec; 18(4):540-550. PubMed ID: 27209362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
    Tan L; Yu JT; Tan L
    Mol Neurobiol; 2015; 51(3):1249-62. PubMed ID: 24973986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synaptic plasticity and depression: the role of miRNAs dysregulation.
    Rahmani S; Kadkhoda S; Ghafouri-Fard S
    Mol Biol Rep; 2022 Oct; 49(10):9759-9765. PubMed ID: 35441941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
    Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory triangle of neurodegeneration, adult neurogenesis and microRNAs.
    Singh T; Jauhari A; Pandey A; Singh P; Pant AB; Parmar D; Yadav S
    CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):96-103. PubMed ID: 24152328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.
    Catanesi M; d'Angelo M; Tupone MG; Benedetti E; Giordano A; Castelli V; Cimini A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in brain aging.
    Danka Mohammed CP; Park JS; Nam HG; Kim K
    Mech Ageing Dev; 2017 Dec; 168():3-9. PubMed ID: 28119001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs and Child Neuropsychiatric Disorders: A Brief Review.
    Paul S; Reyes PR; Garza BS; Sharma A
    Neurochem Res; 2020 Feb; 45(2):232-240. PubMed ID: 31773374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
    Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs in neurodegenerative diseases and their therapeutic potential.
    Junn E; Mouradian MM
    Pharmacol Ther; 2012 Feb; 133(2):142-50. PubMed ID: 22008259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease.
    Tung CW; Huang PY; Chan SC; Cheng PH; Yang SH
    J Biomed Sci; 2021 Aug; 28(1):59. PubMed ID: 34412645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer's Disease.
    Ghaffari M; Sanadgol N; Abdollahi M
    Mini Rev Med Chem; 2020; 20(15):1499-1517. PubMed ID: 32400332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory Role of MicroRNAs in Brain Development and Function.
    Yapijakis C
    Adv Exp Med Biol; 2020; 1195():237-247. PubMed ID: 32468482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
    Eyileten C; Sharif L; Wicik Z; Jakubik D; Jarosz-Popek J; Soplinska A; Postula M; Czlonkowska A; Kaplon-Cieslicka A; Mirowska-Guzel D
    Mol Neurobiol; 2021 Jan; 58(1):329-347. PubMed ID: 32944919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.